EA Series Trust’s Bristol-Myers Squibb BMY Stock Holding History

EA Series Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2.53M	Buy	+39,579	New	+$2.65M	0.09%	323

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EA Series Trust's BMY Position: Q2 2023 in Review

EA Series Trust opened a new position in Bristol-Myers Squibb (BMY) in Q2 2023: 39,579 shares worth $2.53M. The stake represents 0.09% of the portfolio and ranks #323 among its holdings.

2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

EA Series Trust held 39,579 shares of Bristol-Myers Squibb worth $2.53M as of Q2 2023.
Bristol-Myers Squibb was a new EA Series Trust position in Q2 2023.
Bristol-Myers Squibb made up 0.09% of EA Series Trust's portfolio in Q2 2023, its #323 holding.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.